Suspension Culture Enables Serosal Mesothelial Layer in Intestinal Organoids

Study Background and Research Question

Human intestinal organoids (HIOs), derived from pluripotent stem cells, have become a pivotal model for studying intestinal development, physiology, and disease. Traditionally, HIOs are cultured in three-dimensional extracellular matrix (ECM) systems such as Matrigel, which facilitate organoid growth and enable partial recapitulation of intestinal architecture. However, these matrices introduce biological variability, high costs, and xenogeneic components, limiting reproducibility and translational potential. Notably, established methods have struggled to recapitulate some specialized cell types and complex tissue organizations found in native human intestine—particularly the serosal mesothelium, the outermost protective layer. Capeling et al. addressed whether suspension culture, eliminating the need for exogenous ECM, could support HIO growth and drive development of a serosal mesothelial compartment (Capeling et al., 2022).

Key Innovation from the Reference Study

The central innovation of this study is the demonstration that HIOs can be robustly cultured in suspension, without any hydrogel or ECM scaffold, and that this method promotes the formation of a serosal mesothelial-like layer. This development closely mimics the serosa observed in the fetal human intestine, both in cellular composition and organization. Importantly, the study shows that the suspension environment enhances mesenchymal patterning and enables functional differentiation of serosal mesothelial cells—features not reliably achieved in conventional ECM-embedded cultures. This provides a new avenue for modeling serosal biology and its roles in intestinal development and disease.

Methods and Experimental Design Insights

The authors generated HIOs from human pluripotent stem cells using established stepwise differentiation methods. Instead of embedding organoids in Matrigel or alginate hydrogels, they transferred mature HIOs into suspension culture. Organoids were maintained in low-adherence conditions, allowing them to float freely in the medium. The team employed single-cell RNA sequencing (scRNA-seq) to evaluate cellular composition, and immunohistochemistry to assess tissue organization and marker expression. Functional assays, including differentiation potential and fibrinolytic activity, were used to probe serosal mesothelial cell properties. An inhibitor screen was performed to interrogate the roles of major developmental signaling pathways, including Hedgehog and Wnt, in serosal mesothelial differentiation.

Protocol Parameters

• Suspension transfer: Mature HIOs are gently removed from ECM and transferred to low-attachment plates in defined organoid medium.
• Culturing timeframe: Suspension culture is maintained for several days to weeks, allowing for serosal mesothelial layer development (specific durations optimized per experimental objective).
• Signaling modulation: Pathway inhibitors (e.g., Wnt or Hedgehog) can be added to the medium to dissect regulatory influences on mesothelial differentiation.
• Functional assessment: scRNA-seq and immunostaining are recommended for evaluating lineage specification and tissue architecture.

Core Findings and Why They Matter

Capeling et al. found that HIOs cultured in suspension not only maintain key epithelial cell types but also consistently develop an outer serosal mesothelial-like layer. Transcriptomic analyses revealed that these cells share strong molecular and phenotypic similarity to primary human fetal intestinal serosa. Histologically, the suspension-cultured HIOs exhibited a distinct, continuous outer layer of squamous mesothelial cells—features lacking or poorly organized in ECM-based cultures.

Functionally, the serosal mesothelium derived in vitro demonstrated the capacity to differentiate into smooth muscle-like cells and exhibited fibrinolytic activity, indicating physiologically relevant properties. The inhibitor screen revealed that Hedgehog and Wnt/β-catenin signaling pathways are key regulators of serosal mesothelial development, with pharmacological manipulation of these pathways influencing mesothelial differentiation and organization. This finding is particularly notable, as it links established pathways involved in embryonic development—such as Wnt/β-catenin signaling pathway modulation—to the emergence of previously inaccessible cell types in organoid models.

The study's methodology also offers practical advantages: suspension culture is simpler, more scalable, and less expensive than ECM-based protocols, while reducing biological variability. This positions the approach as a promising tool for developmental biology research, disease modeling, and potentially regenerative medicine.

Comparison with Existing Internal Articles

The role of Wnt/β-catenin signaling and GSK-3 inhibition in organoid and stem cell biology is well established in related literature. Internal analyses, such as "CHIR-99021 (CT99021): Next-Generation GSK-3 Inhibition for Stem Cell Applications", emphasize the importance of selective GSK-3 inhibitors like CHIR-99021 in modulating pluripotency and lineage specification. While Capeling et al. focus specifically on the emergence of serosal mesothelium in intestinal organoids, the mechanistic insight that Wnt/β-catenin activation (often achieved via GSK-3 inhibition) drives complex tissue organization is echoed in these internal reviews. For example, the discussion of limb organoid modeling highlights how CHIR-99021 can orchestrate multi-lineage development through spatial regulation of signaling centers. This underscores a shared conceptual thread: precise pathway modulation, whether via genetic or pharmacological approaches, is crucial for expanding the cell type and tissue complexity achievable in organoid systems.

In contrast, Capeling et al.'s suspension culture approach provides a method to unveil new differentiation outcomes without the need for exogenous matrix components, broadening the toolkit for stem cell and organoid researchers interested in serosal, mesenchymal, or smooth muscle biology.

Limitations and Transferability

Despite its promise, the suspension culture technique described by Capeling et al. has several limitations. First, the model, while recapitulating many aspects of fetal serosal mesothelium, does not fully reproduce the vascularization, innervation, or immune complexity of the native intestine. The absence of ECM may also influence other aspects of organoid maturation or long-term maintenance that remain to be fully characterized. Additionally, while the serosal layer forms robustly in this system, the generalizability of the approach to other organoid types or to later developmental stages requires further study. The reliance on pharmacological pathway modulation (e.g., of Wnt and Hedgehog) also necessitates careful dosing and timing optimization to avoid off-target effects or unintended lineage bias.

Research Support Resources

For researchers aiming to modulate Wnt/β-catenin signaling in organoid or stem cell models, selective GSK-3 inhibitors are an indispensable tool. CHIR-99021 (CT99021) (SKU A3011) is a potent and selective GSK-3α/β inhibitor, frequently used to promote pluripotency and to direct differentiation outcomes, including those relevant to mesothelial, cardiomyogenic, and neuronal lineages. According to the product information, CHIR-99021 is recommended for use at 8 μM in vitro to activate canonical Wnt/β-catenin signaling pathways and is compatible with workflows similar to those described by Capeling et al. Researchers can obtain further details and experimental recommendations from APExBIO to ensure optimal application in their own organoid studies.